Remember When the US Dominated the Drug Industry, Too? Pfizer (PFE) Hits 10-Year Low

Pfizer (PFE), the once mighty stock that couldn’t lose, hit a 10-year low yesterday. Expiring patents and the generic drug fights that follow are weighing on the stock. Lawsuit-besieged Merck’s (MRK) not doing much better.

If the US wants to restore its dominance of this industry, it will likely have to lighten some of the regulatory and legal hurdles these companies face. Otherwise, drug development, too, is headed for China (Chart from CrossingWallStreet):

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at

Tagged In